Series C - NiKang Therapeutics - May 26, 2021 Funding Round Profile - Cointime

Bitcoin $96,371.43 -0.14%
Ethereum $3,582.74 -1.72%
BNB $656.62 +0.73%
Optimism $2.35 -3.24%
Arbitrum $0.91 -3.30%
Solana $238.80 -2.34%
Polygon $0.57 +0.80%
Cosmos $8.32 +0.25%
Avalanche $43.22 -1.19%

Bitcoin $96,371.43 -0.14%
Ethereum $3,582.74 -1.72%
BNB $656.62 +0.73%
Optimism $2.35 -3.24%
Arbitrum $0.91 -3.30%
Solana $238.80 -2.34%
Polygon $0.57 +0.80%
Cosmos $8.32 +0.25%
Avalanche $43.22 -1.19%

NiKang Therapeutics

company

Funding Round

Series C

Money Raised

$ 200M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail
Pavilion Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 14, 2020	Series B	$ 50M	Octagon Investments,Lilly Asia Ventures	Detail